{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "69729-137",
      "generic_name": "Cetirizine Hydrochloride",
      "labeler_name": "OPMX LLC",
      "brand_name": "Pentrexcilina Day time",
      "active_ingredients": [
        {
          "name": "CETIRIZINE HYDROCHLORIDE",
          "strength": "10 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "69729-137-14",
          "description": "14 TABLET in 1 BOTTLE (69729-137-14)",
          "marketing_start_date": "20241115",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "OPMX LLC"
        ],
        "rxcui": [
          "1014678"
        ],
        "spl_set_id": [
          "26f56cb7-be58-a0c2-e063-6294a90a15fa"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "64O047KTOA"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET",
      "spl_id": "26f56cb7-be59-a0c2-e063-6294a90a15fa",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20241115",
      "product_id": "69729-137_26f56cb7-be59-a0c2-e063-6294a90a15fa",
      "application_number": "ANDA209274",
      "brand_name_base": "Pentrexcilina Day time",
      "pharm_class": [
        "Histamine H1 Receptor Antagonists [MoA]",
        "Histamine-1 Receptor Antagonist [EPC]"
      ]
    }
  ]
}